Promoting INformed Approaches in Precision Oncology and ImmuNoTherapy
Completed · Not applicable
Conditions studied: Clinical Trials, Immunotherapy
In brief
The purpose of the research is to: develop an educational website to empower Black and African American cancer patients to make informed decisions about personalized cancer treatment and clinical trials. The sample size for the qualitative interviews was (n=48) when saturation was achieved. With a goal of (n=33) for the pilot trial, the overall target sample size for the study is (n=81).
Key facts
- Study ID
- NCT05034289
- Run by
- Rutgers, The State University of New Jersey
- People needed
- 81
- Starts
- 2021-07-12
- Expected to finish
- 2023-05-19
- Last updated by the study team
- 2026-05-18
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Patient Key Informant:
- Age 18 and older
- Self-identify as Black/African American
- Diagnosed with solid tumor
- Able to read and speak English fluently
- Able to provide informed consent
- Able to complete 1 survey and an in-depth interview
- Relative Key Informant:
- Age 18 and older
- Spouse, blood relative, or caregiver of a cancer patient who identifies as Black/African American
- Able to read and speak English fluently
- Able to provide informed consent
- Able to complete 1 survey and an in-depth interview
- Provider Key Informant:
- Age 18 and older
- Physician, nurse, social worker, patient navigator, or financial counselor
- Work in oncology setting
- Able to read and speak English fluently
- Able to provide informed consent
- Able to complete 1 survey and an in-depth interview
- Pilot Tester:
- Age 18 and older
- Self-identify as Black/African American
- Able to read and speak English fluently
- Able to provide informed consent
You may not qualify if…
- Key informants will be excluded from the study if they do not meet the inclusion criteria. Pilot testers will be excluded from the study if they previously participated as key informants and do not meet inclusion criteria.
Where it is running
- The Rutgers Cancer Institute — New Brunswick, New Jersey, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.